Correlation between gastrointestinal hormones and anxiety-depressive states in irritable bowel syndrome
Author:
Open Access
- 9 July 2013
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 6 (3) , 715-720
Abstract
The aim of this study was to investigate the mechanism(s) of action of gastrointestinal hormones in the pathogenesis of irritable bowel syndrome (IBS), and the correlation between gastrointestinal hormones and psychological factors. Patients with IBS were divided into IBS with normal emotional state ratings and IBS in anxiety-depressive states groups. The two groups were then subdivided into IBS-constipation predominant (IBS-C) and IBS-diarrhea predominant (IBS-D) groups. Non-IBS patients with normal depression and anxiety ratings were recruited as controls. The serum concentrations of somatostatin (SS) and vasoactive intestinal peptide (VIP) were measured by radioimmunoassay, and the expression of SS and VIP in the colonic mucosa was detected by immunohistochemistry and radioimmunoassay. The anxiety-depression scores of patients with IBS were significantly different from those of the control group (P0.05). In addition, the expression levels of SS and VIP in the IBS groups with normal emotional state ratings were notably different from those in the IBS groups in anxiety-depressive states (P<0.05). Anxiety-depressive states may lead to changes in the secretion of SS and VIP, and subsequently to changes in gastrointestinal motility and function.Keywords
This publication has 24 references indexed in Scilit:
- Visceral hypersensitivity in irritable bowel syndromeJournal of Gastroenterology and Hepatology, 2011
- Pathophysiological and Psychosocial Study in Patients With Functional VomitingJournal of Neurogastroenterology and Motility, 2010
- The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritisGut, 2007
- Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5‐HT signalling and metabolism in human diseaseNeurogastroenterology & Motility, 2007
- Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled TrialDigestive Diseases and Sciences, 2007
- Functional Bowel DisordersGastroenterology, 2006
- Irritable Bowel SyndromeAnnual Review of Medicine, 2001
- The Corticosteroid Receptor Hypothesis of DepressionNeuropsychopharmacology, 2000
- SOMATOSTATIN AND IRRITABLE BOWEL SYNDROMEThe Lancet, 1987
- A Rating Instrument For Anxiety DisordersPsychosomatics, 1971